Seeking Alpha

SciClone Pharmaceuticals (SCLN): Q2 EPS of $0.20 beats by $0.02. Revenue of $40.3M (+21.8% Y/Y)...

SciClone Pharmaceuticals (SCLN): Q2 EPS of $0.20 beats by $0.02. Revenue of $40.3M (+21.8% Y/Y) in-line. Shares +0.4% AH. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)